Extensive phenotypic characterisation of a human TDP-43Q331K transgenic mouse model of amyotrophic lateral sclerosis (ALS)
Abstract The majority of preclinical studies in ALS have relied on transgenic models with overexpression of mutant human superoxide dismutase 1 (SOD1), widely regarded to have failed in terms of translation of therapeutic effects. However, there are still no widely accepted models of other genetic s...
Guardado en:
Autores principales: | Jodie A. Watkins, James J. P. Alix, Pamela J. Shaw, Richard J. Mead |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b3bf81e102784ceca1bb400b40642252 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Female sex mitigates motor and behavioural phenotypes in TDP-43Q331K knock-in mice
por: Jodie Watkins, et al.
Publicado: (2021) -
TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis.
por: Rita J Guerreiro, et al.
Publicado: (2008) -
The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS
por: Amy Keerie, et al.
Publicado: (2021) -
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis
por: Elisa Conti, et al.
Publicado: (2021) -
Thioridazine reverts the phenotype in cellular and Drosophila models of amyotrophic lateral sclerosis by enhancing TDP-43 aggregate clearance
por: Lucia Cragnaz, et al.
Publicado: (2021)